About
Innovative therapies and delivery methods
Areas of Focus
Categories
Small Molecule PharmaceuticalDrug Delivery & FormulationSeattle/Pacific Northwest
Team (10)
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
510
By Phase
PHASE2: 4PHASE1: 1PHASE3: 1
By Status
COMPLETED: 4RECRUITING: 1ACTIVE_NOT_RECRUITING: 1TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05607004Lead Sponsor
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
PHASE2Recruiting
87 participants
Started: Feb 14, 2023 · Completed: Apr 30, 2027
NCT05068388Lead Sponsor
Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
PHASE2Active, not recruiting
240 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
NCT04519788Lead Sponsor
AT-301 Nasal Spray in Healthy Adults
PHASE1Completed
32 participants
Started: Aug 7, 2020 · Completed: Jan 12, 2021
NCT04616430Lead Sponsor
Topical Endoxifen in Women
PHASE2Completed
90 participants
Started: Apr 9, 2018 · Completed: Sep 4, 2019
NCT02540330Lead Sponsor
A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
PHASE2Terminated
3 participants
Started: Mar 31, 2016 · Completed: Aug 13, 2020
Locations (1)
Headquarters
Seattle, WA, United States
Map
Loading map...